ArticleOncology research2023

CHRM3 is a novel prognostic factor of poor prognosis and promotes glioblastoma progression via activation of oncogenic invasive growth factors.

Bin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.